Interestingly, while no difference in the expression levels of hsa-miR-nov7 was observed between breast cancer subgroups, we found a significant difference in the expression levels of has-miR-nov3 related to estrogen receptor status. The gene discussed is ESR1; the disease is breast carcinoma.